Eric Horwitz
Papers
1
Total Citations
28
H-Index
1
About
Eric Horwitz is a leading figure in radiation oncology, whose research has fundamentally shaped the treatment of prostate cancer. His primary focus lies in the clinical application and comparative effectiveness of stereotactic body radiation therapy (SBRT), particularly evaluating robotic arm versus gantry linear accelerator platforms. Horwitz’s major contributions include pioneering work that demonstrated the safety and efficacy of SBRT for prostate cancer, offering a highly precise, non-invasive alternative that compresses treatment into just five fractions over two weeks. His landmark 2016 study, which has garnered 28 citations, directly compared these two delivery systems, providing critical data that helps clinicians choose the optimal technology for their patients. Beyond this, his research has been instrumental in establishing SBRT as a popular, standard-of-care option for localized disease, significantly improving patient convenience and quality of life. Through his rigorous clinical trials and comparative analyses, Horwitz has not only advanced the technical precision of radiation delivery but also set new benchmarks for treatment outcomes in genitourinary oncology.
Research Focus
Key Achievements
Top Papers
- 1